Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goserelin for Ovarian Protection in Breast Cancer (ZORO)
NCT00196846Phase 2Completed
- Sponsor
- GBG Forschungs
- Start
- Mar 2005
- Primary completion
- Dec 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of goserelin in primary ovarian insufficiency (POI), sponsored by GBG Forschungs. Started Mar 2005; status: completed.
02
Drugs
goserelin
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT00196846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00196846.